MP:0000578 | ulcerated paws | "inflammatory, often suppurating lesions on the paws; often become necrotic" [J:17194] |
Show
Allelic Composition: Epb41l5tm1Sia/Epb41l5tm1Sia Genetic Background: Not Specified
|
MP:0001793 | altered susceptibility to infection | "a change in the likelihood that an organism will develop ill effects from a pathogenic invasion or from components of or toxins produced by pathogens " [Stedman s Medical Dictionary:ISBN 0-683-40008-8, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Mavstm1Aki/Mavstm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0001798 | impaired macrophage phagocytosis | "reduced ability of these phagocytic cells to internalize particulate matter" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Cited1tm1Dunw/Cited1+ Genetic Background: B6.129P2-Cited1tm1Dunw
|
MP:0001805 | decreased IgG | "less than normal immunoglobulin class G level" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Mavstm1Aki/Mavstm1Aki Genetic Background: Not Specified
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0001856 | myocarditis | "inflammation of the heart walls" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0002089 | abnormal postnatal growth/weight/body size | "increased or decreased average body size, weight or growth characteristic abnormalities manifesting after birth" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Stx1atm1Tfuj/Stx1a+ Genetic Background: B6.Cg-Stx1atm1Tfuj
|
MP:0002310 | resistance to fatty liver development | "less likely than the norm to to develop hepatic steatosis " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Stx1atm1Tfuj/Stx1a+ Genetic Background: B6.Cg-Stx1atm1Tfuj
|
MP:0002376 | abnormal dendritic cell physiology | "failure or atypical function of the immunocompetent cells of the lymphoid and hemopoietic systems and skin, which function to process antigens and present them to T cells, thus stimulating cellular immunity" [MeSH:National Library of Medicine - Medical Subject Headings , 2003, J:85808] |
Show
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
Allelic Composition: Myd88tm1Aki/Myd88tm1Aki,Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
|
MP:0002410 | decreased susceptibility to viral infection | "reduced likelihood that an organism will develop ill effects from a viral infection or from components of or toxins produced by a virus " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Cited1tm1Dunw/Cited1+ Genetic Background: B6.129P2-Cited1tm1Dunw
|
MP:0002411 | decreased susceptibility to bacterial infection | "reduced likelihood that an organism will develop ill effects from a bacterial infection or from components of or toxins produced by bacteria " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Pax61Jrt/Pax6+ Genetic Background: C3.B6-Pax61Jrt
|
MP:0002412 | increased susceptibility to bacterial infection | "greater likelihood that an organism will develop ill effects from a bacterial infection or from components of or toxins produced by bacteria" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Lgi1tm1.1Ics/Lgi1tm1.1Ics Genetic Background: involves: 129S2/SvPas * BALB/c * C57BL/6
|
MP:0002418 | increased susceptibility to viral infection | "greater likelihood that an organism will develop ill effects from a viral infection or from components of or toxins produced by a virus" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Pax61Jrt/Pax6+ Genetic Background: C3.B6-Pax61Jrt
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Ticam1tm1Tsse/Ticam1tm1Tsse,Tg(PVR)1Kkst/0 Genetic Background: involves: 129 * C57BL/6 * ICR
|
MP:0002451 | abnormal macrophage physiology | "abnormal function or response of the phagocytic leukocytes involved in innate immunity, early non-adaptive phases of host-defense, antigen presentation, and which act as effector cells in humoral and cell-mediated immunity" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Pax61Jrt/Pax6+ Genetic Background: C3.B6-Pax61Jrt
Allelic Composition: Ticam1Lps2/Ticam1Lps2,Myd88tm1Aki/Myd88tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
Allelic Composition: Myd88tm1Aki/Myd88tm1Aki,Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
Allelic Composition: Ticam1M2Btlr/Ticam1M2Btlr Genetic Background: C57BL/6J-Ticam1M2Btlr
Allelic Composition: Ticam1M2Btlr/Ticam1+ Genetic Background: C57BL/6J-Ticam1M2Btlr
|
MP:0002459 | abnormal B cell physiology | "abnormal function of B lymphocytes" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Cited1tm1Dunw/Cited1+ Genetic Background: B6.129P2-Cited1tm1Dunw
|
MP:0003009 | abnormal cytokine secretion | "impairment or increase of the cellular release of any of the non-antibody proteins made by inflammatory leukocytes and some non-leukocytic cells that affect the behavior of other cells " [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7, smb:Susan M. Bello , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Pax61Jrt/Pax6+ Genetic Background: C3.B6-Pax61Jrt
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
Allelic Composition: Ticam1Lps2/Ticam1Lps2 Genetic Background: C57BL/6J-Ticam1Lps2
Allelic Composition: Ticam1M2Btlr/Ticam1M2Btlr Genetic Background: C57BL/6J-Ticam1M2Btlr
Allelic Composition: Ticam1M2Btlr/Ticam1+ Genetic Background: C57BL/6J-Ticam1M2Btlr
|
MP:0003691 | abnormal microglial cell function | "anomalous activity of the small neuroglial cells, possibly of mesodermal origin, which may become phagocytic, in areas of neural damage or inflammation" [hdene:Howard Dene , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
|
MP:0003721 | increased tumor growth/size | "greater than expected development of tumorous growth when compared to controls" [smb:Susan M Bello, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Fgfr1tm1Jpa/Fgfr1tm1Jpa,H2afvTg(Wnt1-cre)11Rth/0 Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * ICR
|
MP:0005025 | response to infection | "the body s reaction to invasion and multiplication of microorganisms in its tissues, or the body s reaction to components of or toxins produced by pathogenic mircroorganisms " [MeSH:National Library of Medicine - Medical Subject Headings , 2003, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Lgi1tm1.1Ics/Lgi1tm1.1Ics Genetic Background: involves: 129S2/SvPas * BALB/c * C57BL/6
|
MP:0005027 | increased susceptibility to parasitic infection | "greater likelihood that an organism will develop ill effects from a parasitic infection or from components of or toxins produced by parasites " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Gli2tm3.1Blnw/Gli2tm3.1Blnw,Ptch1tm1Mps/? Genetic Background: involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C3H * C57BL/6
Allelic Composition: Myd88tm1Aki/Myd88tm1Aki,Ticam1tm1Aki/Ticam1+ Genetic Background: B6.129P2-Myd88tm1Aki Ticam1tm1Aki
|
MP:0005070 | defective NK cell cytolysis | "impaired ability of these cells to destroy or dissolve targeted cells" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:6213] |
Show
Allelic Composition: Fgfr1tm1Jpa/Fgfr1tm1Jpa,H2afvTg(Wnt1-cre)11Rth/0 Genetic Background: involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * ICR
|
MP:0005079 | defective cytotoxic T cell cytolysis | "impaired ability of these cells to destroy or dissolve targeted cells" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, J:6692] |
Show
Allelic Composition: Mavstm1Aki/Mavstm1Aki Genetic Background: Not Specified
|
MP:0005166 | decreased susceptiblity to injury | "less than the normal reaction to trauma, especially that by physical means" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
Allelic Composition: Ticam1Lps2/Ticam1Lps2 Genetic Background: C57BL/6J-Ticam1Lps2/J
|
MP:0005597 | decreased susceptibility to type I hypersensitivity reaction | "less likelihood or resistance to developing a response manifested by localized or generalized reaction that occurs immediately (minutes) after exposure to an antigen to which the person/animal was previously sensitized; it is IgE-mediated, and mast cell activation and degranulation are hallmarks" [Pathology:ISBN 0-397-51047-0, J:68588, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0006071 | abnormal retinal progenitor morphology | "anomoly in the proliferation or differentiation of the cells that give rise to the various cells of the retina" [smb:Susan M Bello, Mouse Genome Informatics Curator, J:92622:] |
Show
Allelic Composition: Ticam1Lps2/Ticam1Lps2 Genetic Background: C57BL/6J-Ticam1Lps2
|
MP:0008042 | abnormal NK T cell physiology | "any functional anomaly of the distinct lineage of T cells expressing natural killer cell markers and having T cell receptors characterized by the usage of a restricted repertoire of variable region gene segments" [GO:0001865] |
Show
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
|
MP:0008079 | decreased CD8-positive T cell number | "reduction in the number of the regulatory subset of T lymphocytes that are involved in MHC class I restricted interactions" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Mavstm1Aki/Mavstm1Aki Genetic Background: Not Specified
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0008217 | abnormal B cell activation | "any anomaly in the normal change in morphology and behavior of a mature or immature B cell during an immune response, resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific" [GO:0002312, MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
|
MP:0008495 | decreased IgG1 level | "less than normal immunoglobulin class G1 level" [MGI:tmeehan "Terry Meehan, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Mavstm1Aki/Mavstm1Aki Genetic Background: Not Specified
|
MP:0008496 | decreased IgG2a level | "less than normal immunoglobulin class G2a level" [MGI:tmeehan "Terry Meehan, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Mavstm1Aki/Mavstm1Aki Genetic Background: Not Specified
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0008539 | decreased susceptibility to induced colitis | "decreased severity or induction threshold of colitis upon treatment of an organism with intestinal inflammation agents such as dextran sodium sulfate (DSS)" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ticam1Lps2/Ticam1Lps2 Genetic Background: C57BL/6J-Ticam1Lps2
|
MP:0008552 | abnormal circulating tumor necrosis factor level | "anomaly in the amount in the blood of a serum glycoprotein produced by activated macrophages and NK cells and involved in initiating local inflammatory responses, particularly by its action on the endothelium of local blood vessels; its actions result in increased vascular permeability and induction of expression of adhesion molecules on the endothelium" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MESH:D12.644.276.374.500.800] |
Show
Allelic Composition: Ticam1Lps2/Ticam1Lps2 Genetic Background: C57BL/6J-Ticam1Lps2
|
MP:0008554 | decreased circulating tumor necrosis factor level | "reduction in the amount in the blood of a serum glycoprotein produced by activated macrophages and NK cells and involved in initiating local inflammatory responses, particularly by its action on the endothelium of local blood vessels; its actions result in increased vascular permeability and induction of expression of adhesion molecules on the endothelium" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MESH:D12.644.276.374.500.800] |
Show
Allelic Composition: Pax61Jrt/Pax6+ Genetic Background: C3.B6-Pax61Jrt
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: B6.129P2-Ticam1tm1Aki
|
MP:0008557 | abnormal interferon-alpha secretion | "anomaly in the production or release of one of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells that has antiviral activity and activates natural killer cells and B cells" [MESH:D12.644.276.374.440.890.250] |
Show
Allelic Composition: Ticam1tm1Tsse/Ticam1tm1Tsse,Tg(PVR)1Kkst/0 Genetic Background: involves: 129 * C57BL/6 * ICR
|
MP:0008561 | decreased tumor necrosis factor secretion | "reduction in the production or release of a serum glycoprotein produced by activated macrophages and NK cells and involved in initiating local inflammatory responses, particularly by its action on the endothelium of local blood vessels; its actions result in increased vascular permeability and induction of expression of adhesion molecules on the endothelium" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MESH:D12.644.276.374.500.800] |
Show
Allelic Composition: Pax61Jrt/Pax6+ Genetic Background: C3.B6-Pax61Jrt
Allelic Composition: Ticam1Lps2/Ticam1Lps2,Myd88tm1Aki/Myd88tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Irak4m1Btlr/Irak4m1Btlr,Ticam1Lps2/Ticam1Lps2 Genetic Background: involves: C57BL/6J
Allelic Composition: Ticam1M2Btlr/Ticam1M2Btlr Genetic Background: C57BL/6J-Ticam1M2Btlr
Allelic Composition: Ticam1M2Btlr/Ticam1+ Genetic Background: C57BL/6J-Ticam1M2Btlr
Allelic Composition: Ticam1M3Btlr/Ticam1M3Btlr Genetic Background: C57BL/6J-Ticam1M3Btlr
Allelic Composition: Ticam1M3Btlr/Ticam1+ Genetic Background: C57BL/6J-Ticam1M3Btlr
|
MP:0008565 | decreased interferon-beta secretion | "reduction in the production or release of one of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA with antiviral, antiproliferative, and immunomodulating activity" [MESH:D12.644.276.374.440.890.275] |
Show
Allelic Composition: Mavstm1Aki/Mavstm1Aki,Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0008574 | decreased circulating interferon-alpha level | "reduction in the amount in the blood of one of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells that has antiviral activity and activates natural killer cells and B cells" [MESH:D12.644.276.374.440.890.250] |
Show
Allelic Composition: Mavstm1Aki/Mavstm1Aki,Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0008576 | decreased circulating interferon-beta level | "reduction in the amount in the blood of one of the type I interferons produced by fibroblasts in response to stimulation by live or inactivated virus or by double-stranded RNA with antiviral, antiproliferative, and immunomodulating activity" [MESH:D12.644.276.374.440.890.275] |
Show
Allelic Composition: Mavstm1Aki/Mavstm1Aki,Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0008578 | decreased circulating interferon-gamma level | "reduction in the amount in the blood of the major interferon produced by mitogenically or antigenically stimulated lymphocytes that is involved in immunoregulation" [MESH:D12.644.276.374.440.893] |
Show
Allelic Composition: Mavstm1Aki/Mavstm1Aki,Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0008597 | decreased circulating interleukin-6 level | "reduction in the amount in the blood of a cytokine that stimulates the growth and differentiation of B-cells and is also a growth factor for hybridomas and plasmacytomas, and is produced by many different cells including T-cells, monocytes and fibroblasts" [MESH:D12.644.276.374.465.506] |
Show
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
Allelic Composition: Mavstm1Aki/Mavstm1Aki,Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0008648 | decreased circulating interleukin-12b level | "reduction in the amount in the blood of the p40 cytokine subunit that is a component of both interleukin-12 and interleukin-23" [MESH:D12.644.276.374.465.512.500] |
Show
Allelic Composition: Mavstm1Aki/Mavstm1Aki,Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0008670 | decreased interleukin-12b secretion | "reduction in the production or release of the p40 cytokine subunit that is a component of both interleukin-12 and interleukin-23" [MESH:D12.644.276.374.465.512.500] |
Show
Allelic Composition: Mavstm1Aki/Mavstm1Aki,Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0008706 | decreased interleukin-6 secretion | "reduction in the production or release of a cytokine that stimulates the growth and differentiation of B-cells and is also a growth factor for hybridomas and plasmacytomas, and is produced by many different cells including T-cells, monocytes and fibroblasts" [MESH:D12.644.276.374.465.506] |
Show
Allelic Composition: Ticam1Lps2/Ticam1Lps2 Genetic Background: C57BL/6J-Ticam1Lps2
|
MP:0008713 | abnormal cytokine level | "deviation from the normal levels of any of the non-antibody proteins made by inflammatory leukocytes and some non-leukocytic cells that affect the behavior of other cells" [ISBN:0-8153-1691-7 "Immunobiology, The Immune System in Health and Disease", MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: B6.129P2-Ticam1tm1Aki
|
MP:0008719 | impaired neutrophil recruitment | "reduced diffusion or accumulation of neutrophils in tissues or cells in response to a wide variety of substances released at the sites of inflammatory reactions" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: B6.129P2-Ticam1tm1Aki
|
MP:0008734 | decreased susceptibility to endotoxin shock | "less than the expected early reaction of the microcirculation to endotoxins such as LPS, characterized by movement of fluid and leukocytes from the blood into extravascular tissues and often resulting in death" [MGI:tmeehan "Terry Meehan, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Pax61Jrt/Pax6+ Genetic Background: C3.B6-Pax61Jrt
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
|
MP:0008750 | abnormal interferon level | "deviation from the normal levels of proteins secreted by vertebrate cells in response to a wide variety of inducers; they confer resistance against many different viruses, inhibit proliferation of normal and malignant cells, impede multiplication of intracellular parasites, enhance macrophage and granulocyte phagocytosis, augment natural killer cell activity, and show several other immunomodulatory functions" [MESH:D12.644.276.374.440] |
Show
Allelic Composition: Ifih1tm1Aki/Ifih1tm1Aki,Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
|
MP:0008751 | abnormal interleukin level | "deviation from the normal levels of soluble factors which stimulate growth-related activities of leukocytes as well as other cell types; they enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli" [MESH:D12.644.276.374.465] |
Show
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
Allelic Composition: Ifih1tm1Aki/Ifih1tm1Aki,Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
|
MP:0008882 | abnormal enterocyte physiology | "any functional anomaly of the epithelial cells that have an apical plasma membrane folded into microvilli to provide ample surface for the absorption of nutrients from the intestinal lumen" [CL:0000584, MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ticam1Lps2/Ticam1Lps2 Genetic Background: C57BL/6J-Ticam1Lps2
|
MP:0009335 | decreased splenocyte proliferation | "reduction in the expansion rate of a splenocyte cell population by cell division" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
|
MP:0009791 | increased susceptibility to viral infection induced morbidity/mortality | "increased likelihood that an organism will display the expected moribund state caused by a viral invasion or from components of or toxins produced by a virus" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
Allelic Composition: Ticam1tm1Tsse/Ticam1tm1Tsse,Tg(PVR)1Kkst/0 Genetic Background: involves: 129 * C57BL/6 * ICR
|
MP:0010181 | decreased susceptibility to weight loss | "smaller decrease in body weight over time when compared to the average decrease in weight in response to dietary modification, fasting or caloric restriction" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0010750 | increased susceptibility to parasitic infection induced morbidity/mortality | "increased likelihood that an organism will display the expected moribund state caused by a parasitic invasion or from components of or toxins produced by parasites" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Gli2tm3.1Blnw/Gli2tm3.1Blnw,Ptch1tm1Mps/? Genetic Background: involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C3H * C57BL/6
Allelic Composition: Myd88tm1Aki/Myd88tm1Aki,Ticam1tm1Aki/Ticam1+ Genetic Background: B6.129P2-Myd88tm1Aki Ticam1tm1Aki
|
MP:0010766 | abnormal NK cell physiology | "any functional anomaly of a lymphocyte that can spontaneously kill a variety of target cells without prior antigenic activation via germline encoded activation receptors, and also regulate immune responses via cytokine release and direct contact with other cells" [GOC:add, ISBN:0781735149, MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator", PMID:15771571] |
Show
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: involves: 129P2/OlaHsd
|
MP:0011077 | decreased macrophage nitric oxide production | "reduced production of macrophage-derived nitric oxide due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Pax61Jrt/Pax6+ Genetic Background: C3.B6-Pax61Jrt
Allelic Composition: Myd88tm1Aki/Myd88tm1Aki,Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: B6.129P2-Myd88tm1Aki Ticam1tm1Aki
Allelic Composition: Myd88tm1Aki/Myd88tm1Aki,Ticam1tm1Aki/Ticam1+ Genetic Background: B6.129P2-Myd88tm1Aki Ticam1tm1Aki
|
MP:0011079 | decreased macrophage cytokine production | "reduced production of macrophage-derived cytokine(s) due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Pax61Jrt/Pax6+ Genetic Background: C3.B6-Pax61Jrt
Allelic Composition: Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: B6.129P2-Ticam1tm1Aki
Allelic Composition: Myd88tm1Aki/Myd88tm1Aki,Ticam1tm1Aki/Ticam1tm1Aki Genetic Background: B6.129P2-Myd88tm1Aki Ticam1tm1Aki
Allelic Composition: Myd88tm1Aki/Myd88tm1Aki,Ticam1tm1Aki/Ticam1+ Genetic Background: B6.129P2-Myd88tm1Aki Ticam1tm1Aki
Allelic Composition: Ticam1M2Btlr/Ticam1M2Btlr Genetic Background: C57BL/6J-Ticam1M2Btlr
Allelic Composition: Ticam1M2Btlr/Ticam1+ Genetic Background: C57BL/6J-Ticam1M2Btlr
|
MP:0011081 | decreased macrophage apoptosis | "reduced incidence of cell death in macrophages" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Pax61Jrt/Pax6+ Genetic Background: C3.B6-Pax61Jrt
|
MP:0013293 | embryonic lethality prior to tooth bud stage | "death prior to the appearance of tooth buds (Mus: E12-E12.5)" [MGI:smb] |
Show
Allelic Composition: Mlkltm1.2Wsa/Mlkltm1.2Wsa,Ripk3tm2Vmd/Ripk3tm2Vmd Genetic Background: involves: C57BL/6 * C57BL/6N
|